Table 9.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1997 to 2006

Recipients with Liver Transplants

  Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Functioning Graft at Discharge 3,581 3,929 4,093 4,319 4,568 4,775 5,119 5,624 5,863 6,139
With Immunosuppression Info 3,429 3,743 3,943 4,302 4,562 4,771 5,113 5,597 5,791 6,043
Corticosteroids Any in Category 94.9% 94.5% 93.0% 91.9% 90.2% 90.4% 82.4% 80.6% 78.9% 78.4%
Steroids 94.9% 94.5% 93.0% 91.9% 90.2% 90.4% 82.4% 80.6% 78.9% 78.4%
Cyclosporine Any in Category 38.3% 31.1% 25.9% 18.5% 11.9% 10.2% 8.7% 8.1% 7.0% 6.7%
Cyclosporin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1%
Sandimmmune 4.3% 4.0% 3.8% 3.1% 1.3% 1.1% 0.4% 0.5% 0.6% 0.8%
Neoral 34.0% 27.0% 22.1% 15.3% 9.6% 7.4% 7.4% 6.6% 5.6% 4.3%
Gengraf 0.0% 0.0% 0.0% 0.1% 0.6% 1.5% 0.8% 0.8% 0.6% 1.0%
Eon 0.0% 0.0% 0.0% 0.0% 0.4% 0.2% 0.1% 0.2% 0.1% 0.5%
Tacrolimus Any in Category 59.0% 67.1% 71.6% 76.6% 83.2% 86.8% 88.8% 88.7% 90.8% 91.2%
Tacrolimus 59.0% 67.1% 71.6% 76.6% 83.2% 86.8% 88.8% 88.7% 90.8% 91.2%
Antimetabolites Any in Category 43.3% 42.1% 44.5% 48.3% 50.8% 51.6% 57.3% 58.4% 61.4% 69.1%
Mycophenolate Mofetil 24.2% 30.2% 36.7% 43.3% 47.7% 48.1% 54.1% 55.8% 58.5% 65.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 2.1% 3.7%
Azathioprine 19.0% 11.6% 7.7% 5.0% 3.0% 3.5% 3.2% 2.1% 0.7% 0.4%
Leflunomide 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cytoxan 0.1% 0.2% 0.1% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.8% 0.6% 9.4% 9.9% 6.6% 4.4% 4.9% 4.0% 3.8%
Sirolimus 0.0% 0.8% 0.5% 9.4% 9.9% 6.6% 4.4% 4.9% 4.0% 3.7%
Everolimus 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.